According to our results, if decreased CXCR4 and HER-2 expressions are present in a tumor, treatment could be continued, whereas absence of change or increased CXCR4 and HER-2 expressions would imply that patients should be treated with another chemotherapeutic regimen. Here, CXCR4 is linked to neoplasm.